BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 32530106)

  • 1. TGFβ2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer.
    Xiao Z; Hu L; Yang L; Wang S; Gao Y; Zhu Q; Yang G; Huang D; Xu Q
    J Cell Mol Med; 2020 Jul; 24(13):7151-7162. PubMed ID: 32530106
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 4. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
    Wang M; Li C; Liu Y; Wang Z
    Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.
    Wu J; Wang Y; Jiang Z
    J Gastrointest Cancer; 2021 Mar; 52(1):150-159. PubMed ID: 32077004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hu J; Yu J; Gan J; Song N; Shi L; Liu J; Zhang Z; Du J
    Aging (Albany NY); 2020 Feb; 12(3):2595-2609. PubMed ID: 32028262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
    Wu Q; Yin G; Lei J; Tian J; Lan A; Liu S
    Front Mol Biosci; 2020; 7():599110. PubMed ID: 33363208
    [No Abstract]   [Full Text] [Related]  

  • 13. PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer.
    Hu L; Zhang P; Sun W; Zhou L; Chu Q; Chen Y
    Medicine (Baltimore); 2020 May; 99(19):e19957. PubMed ID: 32384443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
    Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
    Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
    J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hu Z; Qu S
    Front Immunol; 2021; 12():683572. PubMed ID: 34267752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
    Wang D; Jiao Z; Ji Y; Zhang S
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
    Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
    World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer.
    Sun K; Zhang XD; Liu XY; Lu P
    Front Mol Biosci; 2021; 8():625731. PubMed ID: 34150844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.